EMAIL: SFeldman@olshanlaw.com
DIRECT DIAL: 212.451.2234
| June 10, 2021 |
VIA EMAIL AND EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
| Attention: | Abby Adams and Tim Buchmiller |
| Division of Corporation Finance, | |
| Office of Life Sciences |
| Re: | Alzamend Neuro, Inc. Registration Statement on Form S-1 (No. 333-255955) Registration Statement on Form 8-A (No. 001- ) |
Ladies and Gentlemen:
This letter will serve to withdraw the request for acceleration made yesterday by our client Alzamend Neuro, Inc.
Alzamend Neuro intends to seek acceleration of effectiveness of the above-referenced Registration Statements to 4:00 p.m., Eastern time, on Monday, June 14, 2021, or as soon as possible thereafter, and is re-submitting its request later this afternoon.
Thank you for your assistance.
| Very truly yours, | |
/s/ Spencer G. Feldman | |
| Spencer G. Feldman |
| cc: | Mr. Stephan Jackman Henry C.W. Nisser, Esq. |
